Mia Langbøl

Mrs. Mia Langbøl

Department of Drug Design and Pharmacology, University of Copenhagen, Denmark
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2017 in Neurobiology of Disease
Verified
Journal Article
Closed access
RRRasmus Rydbirk
Rasmus Rydbirk
BEBetina Elfving
Betina Elfving
MAMille Dahl Andersen
Mille Dahl Andersen
Mia LangbølMia Langbøl
Mia Langbøl
JFJonas Folke
Jonas Folke
SASusana Aznar
Susana Aznar

28 January 2019 in Acta Ophthalmologica
Verified
Journal Article
Open access
PDF file
RVRupali Vohra
Rupali Vohra
LDLine Marie Dalgaard
Line Marie Dalgaard
JVJeppe Vibæk
Jeppe Vibæk
Mia LangbølMia Langbøl
Mia Langbøl
LBLinda Hildegaard Bergersen
Linda Hildegaard Bergersen
MKMiriam Kolko
Miriam Kolko
Purpose: To assess novel differences in serum levels of glucose, lactate and amino acids in patients with normal‐tension glaucoma (NTG) compared to age‐matched controls, at baseline and in response to universal hypoxia.Methods: Twelve patients diagnosed with NTG and eleven control subjects underwent normobaric hypoxia for 2 hr. Peripheral venous blood samples were taken at baseline, during hypoxia and in the recovery phase. Serum glucose and lactate levels were measured by a blood gas analyser. Amino acids were analysed by high‐performance liquid chromatography.Results: Baseline levels of lactate and total amino acids were significantly lower in patients with NTG compared to healthy controls. No differences were seen in blood glucose levels between the two groups. Lactate levels remained unchanged during hypoxia in the control group, but increased in patients with NTG. In the recovery phase, total amino acid levels were reduced in the control group, whereas no changes were found in patients with NTG.Conclusion: Reduced serum levels of lactate and total amino acids were identified as potential markers for NTG. Moreover, significant differential regulatory patterns of certain amino acids were found in patients with NTG compared to control subjects. Overall, our results suggest a link between systemic energy metabolites and NTG and support a novel understanding of glaucoma as an inner retinal manifestation of a systemic condition.

15 September 2020 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
Mia LangbølMia Langbøl
Mia Langbøl
Sarkis SaruhanianSarkis Saruhanian
Sarkis Saruhanian
TBThisayini Baskaran
Thisayini Baskaran
DTDaniel Tiedemann
Daniel Tiedemann
ZMZaynab Ahmad Mouhammad
Zaynab Ahmad Mouhammad
MKMiriam Kolko
Miriam Kolko
The main risk factor for primary open-angle glaucoma (POAG) is increased intraocular pressure (IOP). It is of interest that about half of the patients have an IOP within the normal range (normal-tension glaucoma, NTG). Additionally, there is a group of patients with a high IOP but no glaucomatous neurodegeneration (ocular hypertension, OHT). Therefore, risk factors other than IOP are involved in the pathogenesis of glaucoma. Since the retina has a very high oxygen-demand, decreased autoregulation and a fluctuating oxygen supply to the retina have been linked to glaucomatous neurodegeneration. To assess the significance of these mechanisms, we have utilized a human experimental model, in which we stress participants with a fluctuating oxygen supply. Levels of oxidative stress molecules, antioxidants, and lipid mediators were measured in the plasma. Patients with NTG, OHT, and control subjects were found to have similar levels of oxidative stress markers. In contrast, patients with OHT had a higher level of total antioxidant capacity (TAC) and pro-homeostatic lipid mediators. Thus, we suggest that OHT patients manage fluctuating oxygen levels more efficiently and, thus, are less susceptible to glaucomatous neurodegenerations, due to enhanced systemic antioxidant protection.

16 August 2024 in Cellular and Molecular Neurobiology
Verified
Journal Article
Open access
PDF file
Mia LangbølMia Langbøl
Mia Langbøl
ASArevak Saruhanian
Arevak Saruhanian
SSSarkis Saruhanian
Sarkis Saruhanian
DTDaniel Tiedemann
Daniel Tiedemann
TBThisayini Baskaran
Thisayini Baskaran
JRJens Rovelt
Jens Rovelt
Primary open-angle glaucoma (POAG) is subdivided depending on eye pressure. Patients with normal-tension glaucoma (NTG) have never had high intraocular pressure (IOP) measured while patients with ocular hypertension (OHT) have high eye pressure but no signs of glaucoma. Although IOP is considered to be a risk factor for all glaucoma patients, it is reasonable to assume that other risk factors such as inflammation play a role. We aimed to characterize the proteome and cytokine profile during hypoxia in plasma from patients with NTG (n = 10), OHT (n = 10), and controls (n = 10). Participants were exposed to hypoxia for two hours, followed by 30 min of normoxia. Samples were taken before (“baseline”), during (“hypoxia”), and after hypoxia (“recovery”). Proteomics based on liquid chromatography coupled with mass spectrometry (LC–MS) was performed. Cytokines were measured by Luminex assays. Bioinformatic analyses indicated the involvement of complement and coagulation cascades in NTG and OHT. Regulation of high-density lipoprotein 3 (HDL3) apolipoproteins suggested that changes in cholesterol metabolism are related to OHT. Hypoxia decreased the level of tumor necrosis factor-α (TNF-α) in OHT patients compared to controls. Circulating levels of interleukin-1β (IL-1β) and C-reactive protein (CRP) were decreased in NTG patients compared to controls during hypoxia. After recovery, plasma interleukin-6 (IL-6) was upregulated in patients with NTG and OHT. Current results indicate an enhanced systemic immune response in patients with NTG and OHT, which correlates with pathogenic events in glaucoma. Apolipoproteins may have anti-inflammatory effects, enabling OHT patients to withstand inflammation and development of glaucoma despite high IOP. Graphical Abstract

Verified
Journal Article
Open access
PDF file
Mia LangbølMia Langbøl
Mia Langbøl
JRJens Rovelt
Jens Rovelt
ASArevak Saruhanian
Arevak Saruhanian
Sarkis SaruhanianSarkis Saruhanian
Sarkis Saruhanian
DTDaniel Tiedemann
Daniel Tiedemann
MKMiriam Kolko
Miriam Kolko
Glaucoma is a neurodegenerative disease that affects the retinal ganglion cells (RGCs). The main risk factor is elevated intraocular pressure (IOP), but the actual cause of the disease remains unknown. Emerging evidence indicates that metabolic dysfunction plays a central role. The aim of the current study was to determine and compare the effect of universal hypoxia on the metabolomic signature in plasma samples from healthy controls (n = 10), patients with normal-tension glaucoma (NTG, n = 10), and ocular hypertension (OHT, n = 10). By subjecting humans to universal hypoxia, we aim to mimic a state in which the mitochondria in the body are universally stressed. Participants were exposed to normobaric hypoxia for two hours, followed by a 30 min recovery period in normobaric normoxia. Blood samples were collected at baseline, during hypoxia, and in recovery. Plasma samples were analyzed using a non-targeted metabolomics approach based on liquid chromatography coupled with high-resolution mass spectrometry (LC-HRMS). Multivariate analyses were conducted using principal component analysis (PCA) and orthogonal partial least squares-discriminant analysis (OPLS-DA), and univariate analysis using the Wilcoxon signed-rank test and false discovery rate (FDR) correction. Unique metabolites involved in fatty acid biosynthesis and ketone body metabolism were upregulated, while metabolites of the kynurenine pathway were downregulated in OHT patients exposed to universal hypoxia. Differential affection of metabolic pathways may explain why patients with OHT initially do not suffer or are more resilient from optic nerve degeneration. The metabolomes of NTG and OHT patients are regulated differently from control subjects and show dysregulation of metabolites important for energy production. These dysregulated processes may potentially contribute to the elevation of IOP and, ultimately, cell death of the RGCs.

4 October 2024 in Cellular and Molecular Neurobiology
Verified
Journal Article
Open access
PDF file
Mia LangbølMia Langbøl
Mia Langbøl
ASArevak Saruhanian
Arevak Saruhanian
SSSarkis Saruhanian
Sarkis Saruhanian
DTDaniel Tiedemann
Daniel Tiedemann
TBThisayini Baskaran
Thisayini Baskaran
JRJens Rovelt
Jens Rovelt